The Clorox Company (NYSE:CLX) Shares Acquired by Pictet Asset Management Holding SA

Pictet Asset Management Holding SA increased its holdings in shares of The Clorox Company (NYSE:CLX) by 2.5% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 74,605 shares of the company’s stock after acquiring an additional 1,787 shares during the period. Pictet Asset Management Holding SA owned approximately 0.06% of Clorox worth $12,117,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently modified their holdings of CLX. Vanguard Group Inc. grew its holdings in Clorox by 0.8% in the fourth quarter. Vanguard Group Inc. now owns 15,507,152 shares of the company’s stock valued at $2,518,517,000 after purchasing an additional 124,428 shares during the period. State Street Corp grew its stake in Clorox by 3.1% in the 3rd quarter. State Street Corp now owns 8,182,109 shares of the company’s stock valued at $1,332,947,000 after acquiring an additional 245,525 shares during the period. Geode Capital Management LLC increased its holdings in Clorox by 1.1% in the 3rd quarter. Geode Capital Management LLC now owns 3,028,333 shares of the company’s stock worth $491,713,000 after acquiring an additional 33,970 shares in the last quarter. Stifel Financial Corp raised its position in Clorox by 1.7% during the third quarter. Stifel Financial Corp now owns 2,334,826 shares of the company’s stock worth $380,370,000 after acquiring an additional 37,967 shares during the period. Finally, Norges Bank purchased a new position in Clorox during the fourth quarter valued at $259,041,000. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Stock Up 0.4 %

CLX stock opened at $147.79 on Wednesday. The Clorox Company has a one year low of $127.60 and a one year high of $171.37. The firm has a market cap of $18.21 billion, a PE ratio of 40.38, a PEG ratio of 2.62 and a beta of 0.45. The firm’s 50 day moving average price is $150.83 and its 200-day moving average price is $158.74. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.60 and a current ratio of 0.94.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Monday, February 3rd. The company reported $1.55 EPS for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same period last year, the firm posted $2.16 EPS. On average, equities research analysts anticipate that The Clorox Company will post 7.15 EPS for the current year.

Clorox Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd will be paid a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.30%. The ex-dividend date is Wednesday, April 23rd. Clorox’s dividend payout ratio (DPR) is 133.33%.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on CLX. JPMorgan Chase & Co. raised their price target on shares of Clorox from $171.00 to $173.00 and gave the company a “neutral” rating in a research note on Tuesday, February 4th. Royal Bank of Canada restated a “sector perform” rating and issued a $150.00 target price on shares of Clorox in a research report on Thursday, January 30th. StockNews.com cut Clorox from a “buy” rating to a “hold” rating in a research report on Sunday, January 5th. Evercore ISI increased their price objective on Clorox from $145.00 to $155.00 in a research note on Tuesday, February 4th. Finally, Barclays dropped their target price on shares of Clorox from $140.00 to $139.00 and set an “underweight” rating for the company in a report on Thursday, March 27th. Three investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $159.50.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.